期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

中性粒与淋巴细胞比在糖尿病视网膜病变中的应用价值

Application Value of Neutrophil to Lymphocyte Ratio in Diabetic Retinopathy
下载PDF
导出
摘要 21世纪以来,随着糖尿病(Diabetes Mellitus, DM)患病人数的骤增,糖尿病视网膜病变(Diabetic Retinopathy, DR)发生率也大幅度增加。糖尿病视网膜病变作为糖尿病严重的微血管并发症之一,是一种涉及多个机制的复杂疾病。近年来,视网膜炎症在DR的发病机制中起着关键作用。其中中性粒细胞/淋巴细胞比值(Neutrophil-Lymphocyte Ratio, NLR)作为一种廉价且易于测量的实验室指标,用于指示全身炎症已被大量研究,故本文就NLR与糖尿病视网膜病变之间研究作一综述。 Since twenty-first century, with the rapid increase of Diabetes Mellitus (DM) prevalence, the inci-dence of Diabetic Retinopathy (DR) has also increased significantly. Diabetic retinopathy is one of the serious microvascular complications of diabetes. It is a complex disease involving multiple mechanisms. In recent years, retinal inflammation plays a key role in the pathogenesis of DR. Among them, Neutrophil-Lymphocyte Ratio (NLR) is a cheap and easily measured laboratory indi-cator, indicating that systemic inflammation has been studied extensively. In this paper, the re-search on NLR and diabetic retinopathy is reviewed.
作者 易静静 圈启芳
机构地区 青海大学研究生院 青海大学附属医院
出处 《临床医学进展》 2022年第5期3800-3804,共5页 Advances in Clinical Medicine
关键词 糖尿病 糖尿病视网膜病变 中性粒细胞/淋巴细胞比值
分类号 R587.1 [医药卫生—内分泌] R774 [医药卫生—眼科]
  • 相关文献

参考文献5

二级参考文献28

  • 1Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012 [J]. CA GancerJ Clin, 2015, 65(2):87-108.
  • 2Maletzki C, EmmrichJ. Inflammation and immunity in the tumor environment[J]. Dig Dis, 2010, 28(4-5):574-578.
  • 3Azab B, Bhatt VR, PhookanJ, et al. Usefulness of the neutrophi to lymphocyte ratio in predicting short and long-term mortality in breast cancer patients[J]. Ann Surg Oncol, 2012, 19(1):217-224.
  • 4Noh H, Eomm M, Han A. Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients[J].J Breast Cancer, 2013, 16(1):55-59.
  • 5Forget P, MachielsJP, Coulie PG, et al. Neutrophil lymphocyte ra- tio and intraoperative use of ketorolac or diclofenac are prognos- tic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery[J]. Ann Surg Oncol, 2013, 20(Suppl 3): $650-660.
  • 6ChenJ, Deng O, Pan Y, et al. Prognostic value of neutrophil-to- lymphocyte ratio in breast cancer[J]. FEBS Open Bio, 2015, 5:502- 507.
  • 7Okuturlar Y, Gunaldi M, Tiken EE, et al. Utility of peripheral blood parameters in predicting breast cancer risk[J]. Asian Pac J Cancer Prev, 2015, 16(6) :2409-2412.
  • 8Ozyalvacli G, Yesil C, Kargi E, et al. Diagnostic and prognostic importance of the neutrophil lymphocyte ratio in breast cancer[J]. Asian PacJ Cancer Prey, 2014, 15(23):10363-10366.
  • 9Pistelli M, De Lisa M, Ballatore Z, et al. Pre-treatment neutro- phil to lymphocyte ratio maybe a useful tool in predicting surviv- al in early triple negative breast cancer patients[J]. BMC Cancer, 2015, 15:195-203.
  • 10Koh CH, Bhoo-Pathy N, Ng KL, et al. Utility of pre-treat- ment neutrophil- lymphocyte ratio and platelet- lymphocyte ra- tio as prognostic factors in breast cancer[J]. BrJ Cancer, 2015, 113 (1):150-158.

共引文献44

临床医学进展
2022年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部